CAJ | 학술논문

目的探讨对泛大西洋协作组织(TransAtlantic Inter-Society Consensus Working Group,TASC)-D型髂动脉闭塞性病变腔内治疗的疗效.方法回顾性分析自2006年6月至2010年6月,TASC-D型髂动脉病变腔内治疗的26例患者(共31条肢体)的临床资料.单纯髂动脉病变10例,髂动脉合并腹股沟以下病变16例.结果 24例患者(28条肢体)获得成功,技术成功率90.3%(28条/31条),成功的28条肢体临床症状改善率100%(28条/28条),治疗成功者共放置支架44枚,其中8条肢体进行腹股沟以下动脉腔内治疗,3条肢体同时行股-腘人工血管旁路术,8例患者辅助超声消融技术.术后踝-肱指数(ankle-brachial index,ABI)为0.67±0.16,较术前0.37 ±0.15提高,两者差异有统计学意义(t=13.24,P<0.01).随访22例(26条肢体),时间3～44个月,平均(22±11)个月.1年初期通畅率90%(18/20);二期累积通畅率95%(19/20);3年初期通畅率70%(7/10),二期累积通畅率80%(8/10).结论对于难以耐受外科手术的TASC-D型髂动脉病变可以选用腔内治疗.
목적 탐토대범대서양협작조직(TransAtlantic Inter-Society Consensus Working Group,TASC)-D형가동맥폐새성병변강내치료적료효.방법 회고성분석자2006년6월지2010년6월,TASC-D형가동맥병변강내치료적26례환자(공31조지체)적림상자료.단순가동맥병변10례,가동맥합병복고구이하병변16례.결과 24례환자(28조지체)획득성공,기술성공솔90.3%(28조/31조),성공적28조지체림상증상개선솔100%(28조/28조),치료성공자공방치지가44매,기중8조지체진행복고구이하동맥강내치료,3조지체동시행고-객인공혈관방로술,8례환자보조초성소융기술.술후과-굉지수(ankle-brachial index,ABI)위0.67±0.16,교술전0.37 ±0.15제고,량자차이유통계학의의(t=13.24,P<0.01).수방22례(26조지체),시간3～44개월,평균(22±11)개월.1년초기통창솔90%(18/20);이기루적통창솔95%(19/20);3년초기통창솔70%(7/10),이기루적통창솔80%(8/10).결론 대우난이내수외과수술적TASC-D형가동맥병변가이선용강내치료.
Objective To evaluate recanalization for TASC-D type iliac artery lesions.Methods Between June 2006 and June 2010,26 patients with a total of 31 limbs of the TASC-D iliac artery lesions underwent endovascular procedure. Results Technical success rate was 90.3% (28/31).Clinical symptom improvement rate was 100%. Forty-four stents were placed in 28 limbs of the 24 patients.Eleven patients underwent an associated procedure; femoropopliteal endovascular procedures in 8 cases,femoro-popliteal bypass in 3 cases. Eight patients underwent an intravascular ultrasound thrombolysis.Postoperative ankle-brachial index ( ABI) was increased by more than 0. 15 in all patients. Twenty-two patients(26 limbs) were followed-up for 3 -44 mos, the primary patency rate at 12 months was 90% ,and cumulative patency rate was 95%. At 36 months primary patency rate was 70% , and secondary patency rate was 80%. Conclusions Because the technical success rate is high, endovascular techeniques are the choice of therapy in high risk patients with TASC-D type iliac artery lesions.